FRI0120 Serum calprotectin is not predictive for successful dose reduction or discontinuation of tnf inhibitors in ra patients with low disease activity

Abstract

BackgroundDose reduction and discontinuation of TNF inhibitors (TNFi) have been shown feasible in a large proportion of RA patients with low disease activity.1 However, to date, no predictors for successful...